
Akumin AKU
Quarterly report 2023-Q3
added 12-12-2023
Akumin P/E Ratio 2011-2025 | AKU
Annual P/E Ratio Akumin
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.479 | -1.92 | -10.8 | 48.2 | 51.2 | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 51.2 | -10.8 | 17.2 |
P/E Ratio of other stocks in the Diagnostics research industry
| Issuer | P/E Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
-10.3 | - | -6.23 % | $ 30.6 M | ||
|
Accelerate Diagnostics
AXDX
|
-2.76 | - | -61.36 % | $ 2.46 M | ||
|
Brainsway Ltd.
BWAY
|
-37.1 | $ 19.05 | 0.34 % | $ 99.4 M | ||
|
Burning Rock Biotech Limited
BNR
|
-7.25 | $ 21.0 | 1.82 % | $ 226 M | ||
|
Co-Diagnostics
CODX
|
-0.988 | $ 0.18 | -1.55 % | $ 5.28 M | ||
|
Biocept
BIOC
|
-0.185 | - | -13.05 % | $ 7.29 M | ||
|
Chembio Diagnostics
CEMI
|
-0.54 | - | 0.22 % | $ 16.8 M | ||
|
Castle Biosciences
CSTL
|
38.9 | $ 39.22 | -0.24 % | $ 1.09 B | ||
|
Danaher Corporation
DHR
|
39 | $ 229.96 | -0.31 % | $ 168 B | ||
|
DarioHealth Corp.
DRIO
|
-0.73 | $ 10.5 | -1.87 % | $ 298 M | ||
|
BioNano Genomics
BNGO
|
-0.0317 | $ 1.51 | 0.67 % | $ 1.92 M | ||
|
Exact Sciences Corporation
EXAS
|
-10.8 | $ 101.9 | - | $ 18.9 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
-233 | - | - | $ 562 M | ||
|
DexCom
DXCM
|
90.1 | $ 66.82 | -0.37 % | $ 25.8 B | ||
|
Enzo Biochem
ENZ
|
-0.00221 | - | -8.98 % | $ 14.8 K | ||
|
Fulgent Genetics
FLGT
|
-10.9 | $ 26.28 | -0.79 % | $ 795 M | ||
|
Global Cord Blood Corporation
CO
|
0.485 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-9.08 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-1.29 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-3.07 | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
-0.421 | - | -11.32 % | $ 2.94 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
39.9 | - | - | $ 10.7 B | ||
|
CareDx, Inc
CDNA
|
-2.74 | $ 18.79 | -1.49 % | $ 1.01 B | ||
|
Celcuity
CELC
|
-3.57 | $ 99.21 | -0.71 % | $ 3.91 B | ||
|
Heska Corporation
HSKA
|
-42.4 | - | - | $ 1.31 B | ||
|
Anixa Biosciences
ANIX
|
-0.00564 | $ 3.11 | -0.32 % | $ 99.2 K | ||
|
HTG Molecular Diagnostics
HTGM
|
-0.138 | - | -20.0 % | $ 1.06 M | ||
|
IQVIA Holdings
IQV
|
26 | $ 226.18 | -0.65 % | $ 41 B | ||
|
Guardant Health
GH
|
-13.4 | $ 102.07 | 1.46 % | $ 12.5 B | ||
|
Aspira Women's Health
AWH
|
-1.67 | - | -6.19 % | $ 10.5 M | ||
|
Myriad Genetics
MYGN
|
-7.64 | $ 6.17 | - | $ 559 M | ||
|
ENDRA Life Sciences
NDRA
|
-0.191 | $ 4.55 | -4.41 % | $ 2.44 M | ||
|
Neogen Corporation
NEOG
|
-0.933 | $ 7.05 | -0.07 % | $ 1.53 B | ||
|
Koninklijke Philips N.V.
PHG
|
9.27 | $ 27.19 | -0.75 % | $ 20 B | ||
|
Personalis
PSNL
|
-3.12 | $ 7.93 | -0.5 % | $ 470 M | ||
|
Quidel Corporation
QDEL
|
13 | $ 29.0 | -1.02 % | $ 1.22 B | ||
|
National Research Corporation
NRC
|
32.6 | $ 18.42 | -1.26 % | $ 452 M | ||
|
RadNet
RDNT
|
1.32 K | $ 71.33 | -0.22 % | $ 5.21 B | ||
|
Illumina
ILMN
|
-13.4 | $ 131.5 | -0.94 % | $ 20.9 B | ||
|
Charles River Laboratories International
CRL
|
385 | $ 201.1 | -0.44 % | $ 10.3 B | ||
|
Soleno Therapeutics
SLNO
|
-11.1 | $ 45.22 | -2.32 % | $ 1.82 B | ||
|
Quest Diagnostics Incorporated
DGX
|
21.9 | $ 174.8 | -0.4 % | $ 19.4 B | ||
|
Biodesix
BDSX
|
-2.14 | $ 6.61 | -1.64 % | $ 857 M | ||
|
Motus GI Holdings
MOTS
|
-0.0769 | - | -34.28 % | $ 263 K | ||
|
Laboratory Corporation of America Holdings
LH
|
28.3 | $ 252.06 | -0.4 % | $ 21.1 B | ||
|
ICON Public Limited Company
ICLR
|
21 | $ 182.26 | -0.4 % | $ 15 B | ||
|
IDEXX Laboratories
IDXX
|
42.4 | $ 681.09 | -0.18 % | $ 56.2 B | ||
|
Lantheus Holdings
LNTH
|
20.7 | $ 66.97 | -0.28 % | $ 4.63 B | ||
|
Mettler-Toledo International
MTD
|
34.6 | $ 1 404.2 | -0.72 % | $ 29.8 B |